Indice del forum

tuttoesaurito

programmi giochi

PortalPortale  blogBlog  AlbumAlbum  Gruppi utentiGruppi utenti  Lista degli utentiLista degli utenti  GBGuestbook  Pannello UtentePannello Utente  RegistratiRegistrati 
 FlashChatFlashChat  FAQFAQ  CercaCerca  Messaggi PrivatiMessaggi Privati  StatisticheStatistiche  LinksLinks  LoginLogin 
 CalendarioCalendario  DownloadsDownloads  Commenti karmaCommenti karma  TopListTopList  Topics recentiTopics recenti  Vota ForumVota Forum

Uterine fibroid treatment Market Research Report: Forecast u
Utenti che stanno guardando questo topic:0 Registrati,0 Nascosti e 1 Ospite
Utenti registrati: Nessuno


 
Nuovo Topic   Rispondi    Indice del forum -> Forum di prova
PrecedenteInvia Email a un amico.Utenti che hanno visualizzato questo argomentoSalva questo topic come file txtVersione stampabileMessaggi PrivatiSuccessivo
Autore Messaggio
zhangsan

Apprendista
Apprendista


Iscritti

Sesso: Sesso:Maschio
Età: 11
Registrato: 08/07/19 09:00
Messaggi: 88
zhangsan is offline 







italy
MessaggioInviato: Lun Ago 26, 10:53:08    Oggetto:  Uterine fibroid treatment Market Research Report: Forecast u
Descrizione:
Rispondi citando

Uterine fibroid treatment Market Research Report: Forecast up to 2023 Health Articles | June 21
, 2017

Uterine fibroid treatment Market – Industry for Uterine fibroid treatment is dominated by Europe, This report analyzes uterine fibroid treatment on the basis of its market segments, and current market trends



Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid in the uterus. However, fibroids do not always cause any symptoms, their location, and size results to difficulties for few women, including pain, discomfort and heavy bleeding. Uterine fibroid can be of different types such as intramural fibroids, subserosal fibroids, pedunculated fibroids and submucosal fibroids. There can be many reasons for uterine fibroid formation but genetic problems hormonal imbalance and other factors are predominant. The cardinal symptoms of uterine fibroids are heavy menstrual bleeding, abdominal pain, excessive uterine bleeding, increased urinary frequency, anaemia and infertility. Apart from physical morbidity, uterine fibroid ailment is a frequent cause of significant damage of quality of life and a major reason for hysterectomy. Therapy has traditionally based on two extremes: medicinal management, comprising progestins, oral contraceptives and GnRH agonists and surgical management, including myomectomy, hysterectomy, and ablation for most serious cases.


Patients suffering from uterine fibroid problem represent an undeserved and huge market due to the absence of satisfactory medical treatments. Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.


The market for uterine fibroid are divided based on non-hormonal treatment, hormonal treatment, surgical methods and geographically. Non-hormonal treatment are subdivided into non-steroidal anti-inflammatory agents (NSAIDS). Hormonal treatment segmented as Oral contraceptives, ProgestinsAntiprogestins, Gonadotropin-releasing hormone (GnRH) agonists. Surgical Methods are segmented as traditional abdominal myomectomy, laparoscopic or robotic myomectomy, hysteroscopic myomectomy, hysterectomy, uterine artery embolization or fibroid embolization (UAE) and ablation.


View Report-






Some of Major players in uterine fibroid market are Boston Scientific Corporation, Cooper Surgical, C.R. Bard, F. Hoffmann-La Roche Ltd, GE Healthcare, Karl Storz Endoscopy, Richard Wolf Medical Instruments and Siemens Medical Solutions, AbbVie Inc., AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline Pharmaceuticals Limited, Pfizer Inc., Johnson & Johnson and Novartis AG.


The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.





The study is a source of reliable data on:


Market segments and sub-segments


Market trends and dynamics


Supply and demand


Market size


Current trendsopportunitieschallenges


Competitive landscape


Technological breakthroughs


Value chain and stakeholder analysis


The regional analysis covers:


North America (U.S. and Canada)


Latin America (Mexico, Brazil, Peru, Chile, and others)


Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)


Eastern Europe (Poland, Russia)


Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)


Middle East and Africa (GCC, Southern Africa, North Africa)


Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Uterine fibroid treatment Market during 2016- 2023









Technology and Transition Technology Articles | April 23, 2013

Over the last century there has been exponential growth in technology. How able are we to predict the future of technology and what are the social effects of increased technology usage?



Technology and Transition



History and future trends:
The best summary of the history of information technologies is a graph that shows the calculations per second per $1,000 from 1900 to today.[1][2] (Try googling calculations per second per $1,000) What we see when we look at these figures is exponential growth.

Up take of the printing press took hundreds of years; uptake of the radio and TV took decades; uptake of the computer and mobile phones took years. The kitsch and yet astonishing comparison that is usually trotted out in conversations like this is that there is over 100 times more computing power in our smart phone than there was in the Apollo Space Program.

Each time we reach the capacity of one technology, a new one appears that takes the technology to the next level. Vacuum tubes were replaced by transistors, which were replaced by chips, which will probably be replaced by 3 dimensional self-organisin.
Torna in cima
Profilo Messaggio privato
Adv



MessaggioInviato: Lun Ago 26, 10:53:08    Oggetto: Adv



Torna in cima
Mostra prima i messaggi di:   
Nuovo Topic   Rispondi    Indice del forum -> Forum di prova Tutti i fusi orari sono GMT + 1 ora
Pagina 1 di 1

 
Vai a:  
Non puoi inserire nuovi Topic in questo forum
Non puoi rispondere ai Topic in questo forum
Non puoi modificare i tuoi messaggi in questo forum
Non puoi cancellare i tuoi messaggi in questo forum
Non puoi votare nei sondaggi in questo forum
Non puoi allegare files in questo forum
Non puoi downloadare files da questo forum





tuttoesaurito topic RSS feed 
Powered by MasterTopForum.com with phpBB © 2003 - 2008